• Retinopathy Associated With Ritonavir Treatment for HIV Infection: A Case Series Reappraisal in the COVID-19 Era

  • Jan 22 2024
  • Length: 13 mins
  • Podcast

Retinopathy Associated With Ritonavir Treatment for HIV Infection: A Case Series Reappraisal in the COVID-19 Era  By  cover art

Retinopathy Associated With Ritonavir Treatment for HIV Infection: A Case Series Reappraisal in the COVID-19 Era

  • Summary

  • In this episode, Dr. Timothy Murray welcomes Steven Yeh, MD, University of Nebraska Medical Center, Truhlsen Eye Institute to discuss 3 cases of retinopathy secondary to ritonavir use in the treatment of HIV. The review identified 3 patients with a history of HIV treated with antiretroviral therapy including ritonavir who had been evaluated for bilateral vision loss in both eyes. Explore why ritonavir toxicity should be considered in the differential diagnosis of retinopathy among patients with an exposure history.

    For more information visit www.ASRS.org/JVRDForum.

    Welcome to ASRS’s Journal of Vitreoretinal Diseases (JVRD) Author’s Forum. JVRD is the official scientific peer-reviewed journal of the American Society of Retina Specialists (ASRS) offering the highest quality and most impactful research and clinical information in the field. Join host Dr. Timothy Murray, Editor-in-Chief for JVRD as he discusses cutting-edge developments featured in JVRD with the lead authors who share clinical pearls and explore their significance for advancing patient care.

    Audio episodes are available on Amazon Music, Apple Podcasts, Google Podcasts, Spotify, and other podcast directories.

    Show more Show less
activate_primeday_promo_in_buybox_DT

What listeners say about Retinopathy Associated With Ritonavir Treatment for HIV Infection: A Case Series Reappraisal in the COVID-19 Era

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.